Drugs & Side Effects | COX-2 / Arthritis

Vioxx News

Merck Loses Vioxx Trial in New Jersey

RSS News Feeds
Drugs & Pharmacuticals
Stroke
Vioxx
 All RSS Feeds

At a glance:

On the one hand, the plaintiff in this Vioxx case had so many other illnesses, it looked like it would be difficult to prove that Vioxx actually affected him; on the other, it was easy to prove that had he known the risks, he would not have chosen to take Vioxx in the first place.
 
The upshot was, the jury awarded the plaintiff, John McDarby, $9 million in punitive damages and $4.5 million in compensation.
 
Appeals are of course pending.
 
This was the first Vioxx trial in which the plaintiff took the medication for more than the 18 months that Merck now admits is hazardous.

Elderly Vioxx Plaintiff Awarded Another $9 Million

The Ledger - 4/12/2006 7:41 AM

ATLANTIC CITY, N.J. -- At first, John McDarby's case looked like a loser. Frail, elderly and confined to a wheelchair after two broken hips, he was a 77-year-old diabetic with clogged arteries.
 
Not exactly the kind of victim likely to win over a jury with his claim that a painkiller made by Merck & Co. was to blame for his illness. Or so many people thought last fall, when Merck chose McDarby's case as the next involving Vioxx to go to trial.
 
· Read The Full Vioxx Article From The Ledger -->

· Read All Vioxx (Rofecoxib) News Stories -->

Comments On Vioxx News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: